{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:51:33Z","timestamp":1790121093035,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"3\u2013year public health program of Shanghai Municipal Health Commission","award":["GWVI\u201311.1\u201310"],"award-info":[{"award-number":["GWVI\u201311.1\u201310"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473715"],"award-info":[{"award-number":["82473715"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National 2030 Key Research Program of China","award":["2023ZD0500100"],"award-info":[{"award-number":["2023ZD0500100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07399-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:36:50Z","timestamp":1764171410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["D-amino acid oxidase suppresses hepatocellular carcinoma via oxidizing D-amino acids"],"prefix":"10.1186","volume":"23","author":[{"given":"Zishuai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8094-1278","authenticated-orcid":false,"given":"Guangwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"3","key":"7399_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7399_CR2","doi-asserted-by":"publisher","first-page":"906778","DOI":"10.3389\/fonc.2022.906778","volume":"12","author":"J Lin","year":"2022","unstructured":"Lin J, Zhang H, Yu H, et al. Epidemiological characteristics of primary liver cancer in Mainland China from 2003 to 2020: A representative multicenter study. Front Oncol. 2022;12:906778.","journal-title":"Front Oncol"},{"key":"7399_CR3","first-page":"5","volume":"11","author":"Y Feng","year":"2025","unstructured":"Feng Y, Fang L, Cao G. Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer. Hepatoma Res. 2025;11:5.","journal-title":"Hepatoma Res"},{"issue":"5","key":"7399_CR4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, et al. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology. 2023;164(5):766\u201382.","journal-title":"Gastroenterology"},{"key":"7399_CR5","first-page":"20","volume":"11","author":"YX Zou","year":"2025","unstructured":"Zou YX, Li ZY, Zhou XH, et al. Burden of liver cancer in adolescents and young adults aged 15\u201349 years in china: a comprehensive analysis based on the global burden of disease study (1990\u20132021). Hepatoma Res. 2025;11:20.","journal-title":"Hepatoma Res"},{"issue":"10360","key":"7399_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"key":"7399_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.20517\/2394-5079.2023.63","volume":"9","author":"LG Fonseca","year":"2023","unstructured":"Fonseca LG, Carrilho FJ. Current landscape and future directions for systemic treatments of hepatocellular carcinoma. Hepatoma Res. 2023;9:27.","journal-title":"Hepatoma Res"},{"key":"7399_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.20517\/2394-5079.2022.43","volume":"8","author":"MM Li","year":"2022","unstructured":"Li MM, He YT, Liang JK, Guan XY, Ma NF, Liu M. Cancer stem cell-mediated therapeutic resistance in hepatocellular carcinoma. Hepatoma Res. 2022;8:36.","journal-title":"Hepatoma Res"},{"key":"7399_CR9","doi-asserted-by":"publisher","first-page":"768098","DOI":"10.3389\/fimmu.2021.768098","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Deng Y, Li Z, et al. Cancer Evo-Dev: A theory of Inflammation-Induced oncogenesis. Front Immunol. 2021;12:768098.","journal-title":"Front Immunol"},{"issue":"4","key":"7399_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/cac2.12411","volume":"43","author":"H Suzuki","year":"2023","unstructured":"Suzuki H, Iwamoto H, Seki T, et al. Tumor\u2013derived insulin\u2013like growth factor\u2013binding protein\u20131 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors. Cancer Commun (Lond). 2023;43(4):415\u201334.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"7399_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12015-024-10805-4","volume":"21","author":"MH Abbasian","year":"2025","unstructured":"Abbasian MH, Sobhani N, Sisakht MM, et al. Patient-Derived organoids: A Game-Changer in personalized cancer medicine. Stem Cell Rev Rep. 2025;21(1):211\u201325.","journal-title":"Stem Cell Rev Rep"},{"issue":"6378","key":"7399_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, et al. Patient-derived organoids model treatment response of metastatic Gastrointestinal cancers. Science. 2018;359(6378):920\u20136.","journal-title":"Science"},{"issue":"16","key":"7399_CR13","doi-asserted-by":"publisher","first-page":"e2303379","DOI":"10.1002\/advs.202303379","volume":"11","author":"K Xiang","year":"2024","unstructured":"Xiang K, Wang E, Mantyh J, et al. Chromatin remodeling in Patient-Derived colorectal cancer models. Adv Sci (Weinh). 2024;11(16):e2303379.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"7399_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, et al. Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"5","key":"7399_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","volume":"24","author":"S Nuciforo","year":"2018","unstructured":"Nuciforo S, Fofana I, Matter MS, et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 2018;24(5):1363\u201376.","journal-title":"Cell Rep"},{"issue":"5","key":"7399_CR16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","volume":"45","author":"L Xian","year":"2022","unstructured":"Xian L, Zhao P, Chen X, et al. Heterogeneity, inherent and acquired drug resistance in patient\u2013derived organoid models of primary liver cancer. Cell Oncol (Dordr). 2022;45(5):1019\u201336.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1\u20132","key":"7399_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u201338.","journal-title":"Cell"},{"key":"7399_CR18","doi-asserted-by":"publisher","first-page":"216048","DOI":"10.1016\/j.canlet.2022.216048","volume":"555","author":"L Chen","year":"2023","unstructured":"Chen L, Wei X, Gu D, Xu Y, Zhou H. Human liver cancer organoids: biological applications, current challenges, and prospects in hepatoma therapy. Cancer Lett. 2023;555:216048.","journal-title":"Cancer Lett"},{"key":"7399_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2867-13-20","volume":"13","author":"X Tan","year":"2013","unstructured":"Tan X, He S, Han Y, et al. Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients. Cancer Cell Int. 2013;13:20.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"7399_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00726-023-03360-8","volume":"56","author":"SH Yap","year":"2024","unstructured":"Yap SH, Lee CS, Zulkifli ND, Suresh D, Hamase K, Das KT, Rajasuriar R, Leong KH. D\u2013Amino acids differentially trigger an inflammatory environment in vitro. Amino Acids. 2024;56(1):6.","journal-title":"Amino Acids"},{"issue":"36","key":"7399_CR21","doi-asserted-by":"publisher","first-page":"26941","DOI":"10.1016\/S0021-9258(19)74201-X","volume":"268","author":"A D\u2019Aniello","year":"1993","unstructured":"D\u2019Aniello A, D\u2019Onofrio G, Pischetola M, et al. Biological role of D-amino acid oxidase and D\u2013aspartate oxidase. Effects of D\u2013amino acids. J Biol Chem. 1993;268(36):26941\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"7399_CR22","doi-asserted-by":"publisher","first-page":"102273","DOI":"10.1016\/j.xpro.2023.102273","volume":"30","author":"R Gao","year":"2023","unstructured":"Gao R, Tang F, Christofori G. Protocol to screen for Sorafenib resistance regulators using pooled lentiviral ShRNA library and a Sorafenib-resistant hepatocellular carcinoma cell model. STAR Protoc. 2023;30(2):102273.","journal-title":"STAR Protoc"},{"issue":"4","key":"7399_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3892\/ol.2021.13000","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Shao F, Jia W. Upregulation of microfibrillar\u2013associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma. Oncol Lett. 2021;22(4):739.","journal-title":"Oncol Lett"},{"issue":"8","key":"7399_CR24","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s11427-023-2481-3","volume":"67","author":"J Gao","year":"2024","unstructured":"Gao J, Shi X, Sun Y, et al. Deficiency of betaine-homocysteine methyltransferase activates glucose-6-phosphate dehydrogenase (G6PD) by decreasing arginine methylation of G6PD in hepatocellular carcinogenesis. Sci China Life Sci. 2024;67(8):1648\u201365.","journal-title":"Sci China Life Sci"},{"key":"7399_CR25","doi-asserted-by":"publisher","first-page":"735447","DOI":"10.3389\/fonc.2021.735447","volume":"11","author":"X He","year":"2021","unstructured":"He X, Sun H, Jiang Q, et al. Hsa\u2013miR\u20134277 decelerates the metabolism or clearance of Sorafenib in HCC cells and enhances the sensitivity of HCC cells to Sorafenib by targeting cyp3a4. Front Oncol. 2021;11:735447.","journal-title":"Front Oncol"},{"issue":"7","key":"7399_CR26","doi-asserted-by":"publisher","first-page":"BSR20201001","DOI":"10.1042\/BSR20201001","volume":"40","author":"R Huang","year":"2020","unstructured":"Huang R, Yan G, Sun H, et al. Identification of prognostic and metastasis\u2013related alternative splicing signatures in hepatocellular carcinoma. Biosci Rep. 2020;40(7):BSR20201001.","journal-title":"Biosci Rep"},{"issue":"22","key":"7399_CR27","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.3390\/ijms21228522","volume":"21","author":"M Fuentes\u2013Baile","year":"2020","unstructured":"Fuentes\u2013Baile M, Garc\u00eda\u2013Morales P, P\u00e9rez\u2013Valenciano E, et al. Cell death mechanisms induced by CLytA\u2013DAAO chimeric enzyme in human tumor cell lines. Int J Mol Sci. 2020;21(22):8522.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"7399_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00018-007-6558-4","volume":"64","author":"L Pollegioni","year":"2007","unstructured":"Pollegioni L, Piubelli L, Sacchi S, Pilone MS, Molla G. Physiological functions of D-amino acid oxidases: from yeast to humans. Cell Mol Life Sci. 2007;64(11):1373\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"29","key":"7399_CR29","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/j.jchromb.2011.06.028","volume":"879","author":"H Ohide","year":"2011","unstructured":"Ohide H, Miyoshi Y, Maruyama R, Hamase K, Konno R. D\u2013Amino acid metabolism in mammals: biosynthesis, degradation and analytical aspects of the metabolic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(29):3162\u20138.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"14","key":"7399_CR30","doi-asserted-by":"publisher","first-page":"14949","DOI":"10.18632\/aging.103554","volume":"12","author":"FF Cai","year":"2020","unstructured":"Cai FF, Song YN, Lu YY, et al. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma. Aging. 2020;12(14):14949\u201365.","journal-title":"Aging"},{"issue":"8","key":"7399_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23(8):583\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"7399_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1476-4598-8-108","volume":"8","author":"S De Boo","year":"2009","unstructured":"De Boo S, Kopecka J, Brusa D, et al. iNOS activity is necessary for the cytotoxic and Immunogenic effects of doxorubicin in human colon cancer cells. Mol Cancer. 2009;8:108.","journal-title":"Mol Cancer"},{"issue":"7","key":"7399_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H Sies","year":"2022","unstructured":"Sies H, Belousov VV, Chandel NS, et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23(7):499\u2013515.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"7399_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20(9):689\u2013709.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"7399_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","volume":"23","author":"IIC Chio","year":"2017","unstructured":"Chio IIC, Tuveson DA. ROS in cancer: the burning question. Trends Mol Med. 2017;23(5):411\u201329.","journal-title":"Trends Mol Med"},{"key":"7399_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.11.037","volume":"471","author":"M Firczuk","year":"2020","unstructured":"Firczuk M, Bajor M, Graczyk\u2013Jarzynka A, et al. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy. Cancer Lett. 2020;471:1\u201311.","journal-title":"Cancer Lett"},{"issue":"1","key":"7399_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"CL Kuo","year":"2022","unstructured":"Kuo CL, Ponneri Babuharisankar A, Lin YC, et al. Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci. 2022;29(1):74.","journal-title":"J Biomed Sci"},{"issue":"7","key":"7399_CR38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbapap.2018.03.001","volume":"1866","author":"N Fujii","year":"2018","unstructured":"Fujii N, Takata T, Fujii N, Aki K, Sakaue H. D\u2013Amino acids in protein: the mirror of life as a molecular index of aging. Biochim Biophys Acta Proteins Proteom. 2018;1866(7):840\u20137.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"7399_CR39","doi-asserted-by":"crossref","unstructured":"Nagano T, Yamao S, Terachi A, et al. D-amino acid oxidase promotes cellular senescence via the production of reactive oxygen species. Life Sci Alliance. 2019;2(1).","DOI":"10.26508\/lsa.201800045"},{"key":"7399_CR40","doi-asserted-by":"publisher","first-page":"31758","DOI":"10.1038\/srep31758","volume":"6","author":"T Nagano","year":"2016","unstructured":"Nagano T, Nakano M, Nakashima A, et al. Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 2016;6:31758.","journal-title":"Sci Rep"},{"issue":"1","key":"7399_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cgt.2011.59","volume":"19","author":"SM El Sayed","year":"2012","unstructured":"El Sayed SM, Abou El\u2013Magd RM, Shishido Y, et al. D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3\u2013bromopyruvate. Cancer Gene Ther. 2012;19(1):1\u201318.","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"7399_CR42","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/ijc.22982","volume":"122","author":"J Fang","year":"2008","unstructured":"Fang J, Deng D, Nakamura H, et al. Oxystress inducing antitumor therapeutics via tumor\u2013targeted delivery of PEG\u2013conjugated D-amino acid oxidase. Int J Cancer. 2008;122(5):1135\u201344.","journal-title":"Int J Cancer"},{"key":"7399_CR43","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.nano.2019.102122","volume":"24","author":"E Rosini","year":"2020","unstructured":"Rosini E, Pollegioni L. PEG-DAAO conjugate: A promising tool for cancer therapy optimized by protein engineering. Nanomedicine. 2020;24:102122.","journal-title":"Nanomedicine"},{"issue":"6","key":"7399_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","volume":"4","author":"MP Murphy","year":"2022","unstructured":"Murphy MP, Bayir H, Belousov V, et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab. 2022;4(6):651\u201362.","journal-title":"Nat Metab"},{"issue":"10","key":"7399_CR45","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97(10):2499\u2013574.","journal-title":"Arch Toxicol"},{"issue":"2","key":"7399_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","volume":"20","author":"S Kishi","year":"2024","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol. 2024;20(2):101\u201319.","journal-title":"Nat Rev Nephrol"},{"issue":"Pt 3","key":"7399_CR47","doi-asserted-by":"publisher","first-page":"142784","DOI":"10.1016\/j.ijbiomac.2025.142784","volume":"309","author":"H Yu","year":"2025","unstructured":"Yu H, Li S, Liu J, et al. Optimization of D-amino acid oxidase and epoxide hydrolase through high-performance characterization for targeted cancer therapy in sustainable biocatalysis. Int J Biol Macromol. 2025;309(Pt 3):142784.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"7399_CR48","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12967-025-06468-5","volume":"23","author":"Y Tan","year":"2025","unstructured":"Tan Y, Yang L, Xu T, et al. GPX2 Inhibition enhances antitumor efficacy of lenvatinib via promoting Immunogenic cell death in hepatocellular carcinoma. J Transl Med. 2025;23(1):456.","journal-title":"J Transl Med"},{"issue":"1","key":"7399_CR49","doi-asserted-by":"publisher","first-page":"e13417","DOI":"10.1111\/imr.13417","volume":"329","author":"L Li","year":"2025","unstructured":"Li L, Xu T, Qi X. Balanced regulation of ROS production and inflammasome activation in preventing early development of colorectal cancer. Immunol Rev. 2025;329(1):e13417.","journal-title":"Immunol Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07399-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07399-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:04:39Z","timestamp":1764176679000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07399-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7399"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07399-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Eastern Hepatobiliary Surgery Hospital, and written informed consent was obtained from every participant. The animal study protocol was approved by the Ethics Committee for the Welfare of Experimental Animals of the Second Military Medical University (protocol code: 82473715).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1359"}}